Home -> Portfolio

Portfolio

NeuCyte

NeuCyte’s mission is to improve the lives of those affected by Central Nervous System (CNS) related disorders by developing better translatable solutions to accelerate and optimize CNS drug discovery.

READ MORE

Paragon Genomics

Paragon Genomics develops and commercializes rapid, easy-to-use, and ultra-high multiplex PCR-based target enrichment solutions for the Next-Generation Sequencing markets.

READ MORE

DeepBiome

DeepBiome develops first-in-class therapeutics through data mining of human microbiome.

READ MORE

Taproot

Taproot develops next-generation biomaterials for aesthetic fillers and other medical applications.

READ MORE

Arthrosi Therapeutics

Strives to address unmet need in the treatments of gout and chronic kidney diseases

READ MORE